With these two cases, we aimed to present a very rare entity with synchronous existenceof clear cell renal cell carcinoma and collecting duct carcinoma in the same kidneys.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:As in every organ, synchronous multiple cancers are rarely encountered in kidneys.
📊
Key Findings & Data:In the literature, mostlyco-existence of renal cell carcinoma and transitional cell carcinoma was reported.
💡
Conclusion & Impact:With these two cases, we aimed to present a very rare entity with synchronous existenceof clear cell renal cell carcinoma and collecting duct carcinoma in the same kidneys.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
As in every organ, synchronous multiple cancers are rarely encountered in kidneys. In the literature, mostlyco-existence of renal cell carcinoma and transitional cell carcinoma was reported. In the literature, the coexistence of collecting duct carcinoma and clear cell carcinoma was described only for a few cases withdifferent patterns. With these two cases, we aimed to present a very rare entity with synchronous existenceof clear cell renal cell carcinoma and collecting duct carcinoma in the same kidneys.
🔖
Cite This Article
YAVUZSAN, A. H., EKŞİ, M., BAYTEKİN, H., TUĞCU, V. (2019). Aggressive co-existence: Collecting duct and clear cell carcinoma in the same kidney. Turkish Journal of Urology, Cilt: 45 - Sayı: 1, 131–134. https://ajindex.com/articles/379786
Matei DV, Rocco B, Varela R, Verweij F, Scardino E, Renne G, et al. Synchronous collecting duct carcinoma and papillary renal cell carcinoma: a case report and review of the literature. Anticancer Res 2005;25:579-86
Auguet T, Molina JC, Lorenzo A, Vila J, Sirvent JJ, Richart C. Synchronus renal cell carcinoma and Bellini duct carcinoma: a case report on a rare coincidence. World J Urol 2000;18:449-51. [CrossRef] 3. Cho NH, Kim S, Ha MJ, Kim HJ. Simultaneous heterogenotypic renal cell carcinoma: immunohistochemical and karyoptic analysis by comparative genomic hybridization. Urol Int 2004;72:344-8. [CrossRef] 4. Tsai TH, Tang SH, Chuang FP, Wu ST, Sun GH, Yu DS, et al. Ipsilateral synchronous neoplasms of kidney presenting as acute pyelonephritis and bladder metastasis. Urology 2009;73:1163.e9-11
Burch-Smith R, Tannir NM, Resetkova E, Tamboli P, Rao P. Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. Chin J Cancer 2014;33:351-5. [CrossRef] 6. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119-32. [CrossRef] 7. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol 1998;15:54-67
Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson CN, Neumann RD. Collecting duct carcinoma of the kidney. Hum Pathol 1990;21:449-56. [CrossRef] 9. Kwon KA, Oh SY, Kim HY, Kim HS, Lee HY, Kim TM, et al. Clinical features and treatment of collecting duct carcinoma of the kidney from the korean cancer study group genitourinary and gynecology cancer committee. Cancer Res Treat 2014;46:141-7. [CrossRef] 10. Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, Tostain J, et al. Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol 2007;52:1140-5. [CrossRef] 11. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T; Japanese Society of Renal Cancer. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol 2006;176:40-3. [CrossRef] 12. Oudard S, Banu E, Vieillefond A, Fournier L, Priou F, Medioni J, et al. GETUG (Groupe d'Etudesdes Tumeurs Uro-Génitales). Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) study. J Urol 2007;177:1698-702. [CrossRef] 13. Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thio